Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tumor Infiltrating Lymphocytes Target HLA-I Phosphopeptides Derived From Cancer Signaling in Colorectal Cancer

Frontiers in Immunology(2021)10.3389/fimmu.2021.723566Source: DataRank Database

Tumor Infiltrating Lymphocytes Target HLA-I Phosphopeptides Derived From Cancer Signaling in Colorectal Cancer is a research paper published in Frontiers in Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 22 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access22 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: goldTopics (28)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Jennifer G. Abelin ORCID,Stacy A. Malaker ORCID,Paisley T. Myers,Abu Z. Saeed,Lora Steadman

Live enrichment

PubMed:34504498 PMC:PMC8421858

Queen Elizabeth Hospital Birmingham Charity

Grant: RCDE13729

NIAID NIH HHS

Grant: R01 AI033993

National Institutes of Health

Grant: 1R01DE013729-01A1

ORAL HEALTH/CARE DISPARITIES IN HIV MINORITY POPULATIONS

National Institutes of Health

goldLicense: cc-by

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.723566/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.723566/full

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8421858

repositoryhttps://doaj.org/article/c061e36b679342809afb621a520a51ca

repositoryhttps://research.birmingham.ac.uk/en/publications/37c4ac09-9c9b-4e8a-a953-83d763f10a79

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

CD8-Positive T-LymphocytesT-Lymphocytes, CytotoxicLymphocytes, Tumor-InfiltratingCell Line, TumorHumansColorectal NeoplasmsPhosphopeptidesHistocompatibility Antigens Class I

Keywords

Tumor antigensSignaling pathwayCrc (Colorectal Cancer)ImmunopeptidomicsHla-I PhosphopeptidesTil (Tumor Infiltrating Lymphocytes)PhosphopeptidesImmunologyHistocompatibility Antigens Class IRC581-607CD8-Positive T-LymphocytesLymphocytes, Tumor-InfiltratingCell Line, TumorHumansImmunologic diseases. AllergyColorectal NeoplasmsT-Lymphocytes, Cytotoxic

Sustainable Development Goals

SDG 3: 3. Good health

Tumor Infiltrating Lymphocytes Target HLA-I Phosphopeptides Derived From Cancer Signaling in Colorectal Cancer

FAIR Checklist

Authors (11)

Funding (4 grants)

Open Access

Topics

Annotations (Europe PMC)